Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage

Increased nasopharyngeal colonization density has been associated with pneumonia. We used experimental human pneumococcal carriage to investigate whether upper respiratory tract viral infection predisposes individuals to carriage. A total of 101 healthy subjects were screened for respiratory virus b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mucosal immunology 2016-01, Vol.9 (1), p.56-67
Hauptverfasser: Glennie, S, Gritzfeld, J F, Pennington, S H, Garner-Jones, M, Coombes, N, Hopkins, M J, Vadesilho, C F, Miyaji, E N, Wang, D, Wright, A D, Collins, A M, Gordon, S B, Ferreira, D M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 67
container_issue 1
container_start_page 56
container_title Mucosal immunology
container_volume 9
creator Glennie, S
Gritzfeld, J F
Pennington, S H
Garner-Jones, M
Coombes, N
Hopkins, M J
Vadesilho, C F
Miyaji, E N
Wang, D
Wright, A D
Collins, A M
Gordon, S B
Ferreira, D M
description Increased nasopharyngeal colonization density has been associated with pneumonia. We used experimental human pneumococcal carriage to investigate whether upper respiratory tract viral infection predisposes individuals to carriage. A total of 101 healthy subjects were screened for respiratory virus before pneumococcal intranasal challenge. Virus was associated with increased odds of colonization (75% virus positive became colonized vs. 46% virus-negative subjects; P =0.02). Nasal Factor H (FH) levels were increased in virus-positive subjects and were associated with increased colonization density. Using an in vitro epithelial model we explored the impact of increased mucosal FH in the context of coinfection. Epithelial inflammation and FH binding resulted in increased pneumococcal adherence to the epithelium. Binding was partially blocked by antibodies targeting the FH-binding protein Pneumococcal surface protein C (PspC). PspC epitope mapping revealed individuals lacked antibodies against the FH binding region. We propose that FH binding to PspC in vivo masks this binding site, enabling FH to facilitate pneumococcal/epithelial attachment during viral infection despite the presence of anti-PspC antibodies. We propose that a PspC-based vaccine lacking binding to FH could reduce pneumococcal colonization, and may have enhanced protection in those with underlying viral infection.
doi_str_mv 10.1038/mi.2015.35
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4703943</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4020564281</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-7668ae05adf1b2a638ce649a66e4f62fca6e292d9fc051b0cc0b6802302e452a3</originalsourceid><addsrcrecordid>eNplkUtv1TAQhS0EoqWw4QegSGwQKJfx8yabSqgqD6mIDawtxxnfukrsYCdXdMVfr9NbqgIrW5pvzpyZQ8hLChsKvHk_-g0DKjdcPiLHtOWy5kKqx7d_XgOj7RF5lvMVgAKQ_Ck5YrJllAt6TH5_jf0ymNnHUEVXBZPjdGnSddihGSofgpmx6tFhyJir7rra-1QKNvrg0N62TQl7n6e4Aj70fu_7xQy5mmOFvyZMfsQwl54p4DJGG61dBUxK3uzwOXniCowv7t4T8uPj-fezz_XFt09fzj5c1FYINtdbpRqDIE3vaMeM4o1FJVqjFAqnmLNGIWtZ3zoLknZgLXSqAcaBoZDM8BNyetCdlm7E3hZLZQ89FXdlWx2N139Xgr_Uu7jXYgu8FbwIvLkTSPHngnnWo88Wh8EEjEvWdCsFNLJcvqCv_0Gv4pJCWa9QDSjW0C0t1NsDZVPMOaG7N0NBr7mWAXrNVfNV8tVD-_fonyAL8O4A5FIq4aUHM_-XuwEF4rBN</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780628171</pqid></control><display><type>article</type><title>Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Glennie, S ; Gritzfeld, J F ; Pennington, S H ; Garner-Jones, M ; Coombes, N ; Hopkins, M J ; Vadesilho, C F ; Miyaji, E N ; Wang, D ; Wright, A D ; Collins, A M ; Gordon, S B ; Ferreira, D M</creator><creatorcontrib>Glennie, S ; Gritzfeld, J F ; Pennington, S H ; Garner-Jones, M ; Coombes, N ; Hopkins, M J ; Vadesilho, C F ; Miyaji, E N ; Wang, D ; Wright, A D ; Collins, A M ; Gordon, S B ; Ferreira, D M</creatorcontrib><description>Increased nasopharyngeal colonization density has been associated with pneumonia. We used experimental human pneumococcal carriage to investigate whether upper respiratory tract viral infection predisposes individuals to carriage. A total of 101 healthy subjects were screened for respiratory virus before pneumococcal intranasal challenge. Virus was associated with increased odds of colonization (75% virus positive became colonized vs. 46% virus-negative subjects; P =0.02). Nasal Factor H (FH) levels were increased in virus-positive subjects and were associated with increased colonization density. Using an in vitro epithelial model we explored the impact of increased mucosal FH in the context of coinfection. Epithelial inflammation and FH binding resulted in increased pneumococcal adherence to the epithelium. Binding was partially blocked by antibodies targeting the FH-binding protein Pneumococcal surface protein C (PspC). PspC epitope mapping revealed individuals lacked antibodies against the FH binding region. We propose that FH binding to PspC in vivo masks this binding site, enabling FH to facilitate pneumococcal/epithelial attachment during viral infection despite the presence of anti-PspC antibodies. We propose that a PspC-based vaccine lacking binding to FH could reduce pneumococcal colonization, and may have enhanced protection in those with underlying viral infection.</description><identifier>ISSN: 1933-0219</identifier><identifier>EISSN: 1935-3456</identifier><identifier>DOI: 10.1038/mi.2015.35</identifier><identifier>PMID: 25921341</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>631/250/255/1318 ; 631/250/255/2514 ; 631/250/347 ; 631/250/590/2294 ; Adolescent ; Adult ; Allergology ; Amino Acid Sequence ; Antibodies ; Antibodies, Bacterial - biosynthesis ; Bacterial Adhesion ; Bacterial Proteins - chemistry ; Bacterial Proteins - genetics ; Bacterial Proteins - immunology ; Binding Sites ; Biomedical and Life Sciences ; Biomedicine ; Coinfection ; Complement Factor H - chemistry ; Complement Factor H - genetics ; Complement Factor H - immunology ; Epitope Mapping ; Female ; Gastroenterology ; Gene Expression Regulation ; Humans ; Immunity, Innate ; Immunity, Mucosal ; Immunology ; Male ; Middle Aged ; Molecular Sequence Data ; Nasopharynx - immunology ; Nasopharynx - microbiology ; Nasopharynx - virology ; Pneumococcal Infections - immunology ; Pneumococcal Infections - microbiology ; Pneumococcal Infections - pathology ; Pneumococcal Infections - virology ; Protein Binding ; Respiratory Mucosa - immunology ; Respiratory Mucosa - microbiology ; Respiratory Mucosa - virology ; Respiratory Tract Infections - immunology ; Respiratory Tract Infections - microbiology ; Respiratory Tract Infections - pathology ; Respiratory Tract Infections - virology ; Streptococcus pneumoniae - immunology ; Streptococcus pneumoniae - pathogenicity ; Virus Diseases - immunology ; Virus Diseases - pathology ; Virus Diseases - virology</subject><ispartof>Mucosal immunology, 2016-01, Vol.9 (1), p.56-67</ispartof><rights>The Author(s) 2016</rights><rights>Copyright Nature Publishing Group Jan 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-7668ae05adf1b2a638ce649a66e4f62fca6e292d9fc051b0cc0b6802302e452a3</citedby><cites>FETCH-LOGICAL-c442t-7668ae05adf1b2a638ce649a66e4f62fca6e292d9fc051b0cc0b6802302e452a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25921341$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Glennie, S</creatorcontrib><creatorcontrib>Gritzfeld, J F</creatorcontrib><creatorcontrib>Pennington, S H</creatorcontrib><creatorcontrib>Garner-Jones, M</creatorcontrib><creatorcontrib>Coombes, N</creatorcontrib><creatorcontrib>Hopkins, M J</creatorcontrib><creatorcontrib>Vadesilho, C F</creatorcontrib><creatorcontrib>Miyaji, E N</creatorcontrib><creatorcontrib>Wang, D</creatorcontrib><creatorcontrib>Wright, A D</creatorcontrib><creatorcontrib>Collins, A M</creatorcontrib><creatorcontrib>Gordon, S B</creatorcontrib><creatorcontrib>Ferreira, D M</creatorcontrib><title>Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage</title><title>Mucosal immunology</title><addtitle>Mucosal Immunol</addtitle><addtitle>Mucosal Immunol</addtitle><description>Increased nasopharyngeal colonization density has been associated with pneumonia. We used experimental human pneumococcal carriage to investigate whether upper respiratory tract viral infection predisposes individuals to carriage. A total of 101 healthy subjects were screened for respiratory virus before pneumococcal intranasal challenge. Virus was associated with increased odds of colonization (75% virus positive became colonized vs. 46% virus-negative subjects; P =0.02). Nasal Factor H (FH) levels were increased in virus-positive subjects and were associated with increased colonization density. Using an in vitro epithelial model we explored the impact of increased mucosal FH in the context of coinfection. Epithelial inflammation and FH binding resulted in increased pneumococcal adherence to the epithelium. Binding was partially blocked by antibodies targeting the FH-binding protein Pneumococcal surface protein C (PspC). PspC epitope mapping revealed individuals lacked antibodies against the FH binding region. We propose that FH binding to PspC in vivo masks this binding site, enabling FH to facilitate pneumococcal/epithelial attachment during viral infection despite the presence of anti-PspC antibodies. We propose that a PspC-based vaccine lacking binding to FH could reduce pneumococcal colonization, and may have enhanced protection in those with underlying viral infection.</description><subject>631/250/255/1318</subject><subject>631/250/255/2514</subject><subject>631/250/347</subject><subject>631/250/590/2294</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Allergology</subject><subject>Amino Acid Sequence</subject><subject>Antibodies</subject><subject>Antibodies, Bacterial - biosynthesis</subject><subject>Bacterial Adhesion</subject><subject>Bacterial Proteins - chemistry</subject><subject>Bacterial Proteins - genetics</subject><subject>Bacterial Proteins - immunology</subject><subject>Binding Sites</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Coinfection</subject><subject>Complement Factor H - chemistry</subject><subject>Complement Factor H - genetics</subject><subject>Complement Factor H - immunology</subject><subject>Epitope Mapping</subject><subject>Female</subject><subject>Gastroenterology</subject><subject>Gene Expression Regulation</subject><subject>Humans</subject><subject>Immunity, Innate</subject><subject>Immunity, Mucosal</subject><subject>Immunology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Molecular Sequence Data</subject><subject>Nasopharynx - immunology</subject><subject>Nasopharynx - microbiology</subject><subject>Nasopharynx - virology</subject><subject>Pneumococcal Infections - immunology</subject><subject>Pneumococcal Infections - microbiology</subject><subject>Pneumococcal Infections - pathology</subject><subject>Pneumococcal Infections - virology</subject><subject>Protein Binding</subject><subject>Respiratory Mucosa - immunology</subject><subject>Respiratory Mucosa - microbiology</subject><subject>Respiratory Mucosa - virology</subject><subject>Respiratory Tract Infections - immunology</subject><subject>Respiratory Tract Infections - microbiology</subject><subject>Respiratory Tract Infections - pathology</subject><subject>Respiratory Tract Infections - virology</subject><subject>Streptococcus pneumoniae - immunology</subject><subject>Streptococcus pneumoniae - pathogenicity</subject><subject>Virus Diseases - immunology</subject><subject>Virus Diseases - pathology</subject><subject>Virus Diseases - virology</subject><issn>1933-0219</issn><issn>1935-3456</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNplkUtv1TAQhS0EoqWw4QegSGwQKJfx8yabSqgqD6mIDawtxxnfukrsYCdXdMVfr9NbqgIrW5pvzpyZQ8hLChsKvHk_-g0DKjdcPiLHtOWy5kKqx7d_XgOj7RF5lvMVgAKQ_Ck5YrJllAt6TH5_jf0ymNnHUEVXBZPjdGnSddihGSofgpmx6tFhyJir7rra-1QKNvrg0N62TQl7n6e4Aj70fu_7xQy5mmOFvyZMfsQwl54p4DJGG61dBUxK3uzwOXniCowv7t4T8uPj-fezz_XFt09fzj5c1FYINtdbpRqDIE3vaMeM4o1FJVqjFAqnmLNGIWtZ3zoLknZgLXSqAcaBoZDM8BNyetCdlm7E3hZLZQ89FXdlWx2N139Xgr_Uu7jXYgu8FbwIvLkTSPHngnnWo88Wh8EEjEvWdCsFNLJcvqCv_0Gv4pJCWa9QDSjW0C0t1NsDZVPMOaG7N0NBr7mWAXrNVfNV8tVD-_fonyAL8O4A5FIq4aUHM_-XuwEF4rBN</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Glennie, S</creator><creator>Gritzfeld, J F</creator><creator>Pennington, S H</creator><creator>Garner-Jones, M</creator><creator>Coombes, N</creator><creator>Hopkins, M J</creator><creator>Vadesilho, C F</creator><creator>Miyaji, E N</creator><creator>Wang, D</creator><creator>Wright, A D</creator><creator>Collins, A M</creator><creator>Gordon, S B</creator><creator>Ferreira, D M</creator><general>Nature Publishing Group US</general><general>Elsevier Limited</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160101</creationdate><title>Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage</title><author>Glennie, S ; Gritzfeld, J F ; Pennington, S H ; Garner-Jones, M ; Coombes, N ; Hopkins, M J ; Vadesilho, C F ; Miyaji, E N ; Wang, D ; Wright, A D ; Collins, A M ; Gordon, S B ; Ferreira, D M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-7668ae05adf1b2a638ce649a66e4f62fca6e292d9fc051b0cc0b6802302e452a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>631/250/255/1318</topic><topic>631/250/255/2514</topic><topic>631/250/347</topic><topic>631/250/590/2294</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Allergology</topic><topic>Amino Acid Sequence</topic><topic>Antibodies</topic><topic>Antibodies, Bacterial - biosynthesis</topic><topic>Bacterial Adhesion</topic><topic>Bacterial Proteins - chemistry</topic><topic>Bacterial Proteins - genetics</topic><topic>Bacterial Proteins - immunology</topic><topic>Binding Sites</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Coinfection</topic><topic>Complement Factor H - chemistry</topic><topic>Complement Factor H - genetics</topic><topic>Complement Factor H - immunology</topic><topic>Epitope Mapping</topic><topic>Female</topic><topic>Gastroenterology</topic><topic>Gene Expression Regulation</topic><topic>Humans</topic><topic>Immunity, Innate</topic><topic>Immunity, Mucosal</topic><topic>Immunology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Molecular Sequence Data</topic><topic>Nasopharynx - immunology</topic><topic>Nasopharynx - microbiology</topic><topic>Nasopharynx - virology</topic><topic>Pneumococcal Infections - immunology</topic><topic>Pneumococcal Infections - microbiology</topic><topic>Pneumococcal Infections - pathology</topic><topic>Pneumococcal Infections - virology</topic><topic>Protein Binding</topic><topic>Respiratory Mucosa - immunology</topic><topic>Respiratory Mucosa - microbiology</topic><topic>Respiratory Mucosa - virology</topic><topic>Respiratory Tract Infections - immunology</topic><topic>Respiratory Tract Infections - microbiology</topic><topic>Respiratory Tract Infections - pathology</topic><topic>Respiratory Tract Infections - virology</topic><topic>Streptococcus pneumoniae - immunology</topic><topic>Streptococcus pneumoniae - pathogenicity</topic><topic>Virus Diseases - immunology</topic><topic>Virus Diseases - pathology</topic><topic>Virus Diseases - virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Glennie, S</creatorcontrib><creatorcontrib>Gritzfeld, J F</creatorcontrib><creatorcontrib>Pennington, S H</creatorcontrib><creatorcontrib>Garner-Jones, M</creatorcontrib><creatorcontrib>Coombes, N</creatorcontrib><creatorcontrib>Hopkins, M J</creatorcontrib><creatorcontrib>Vadesilho, C F</creatorcontrib><creatorcontrib>Miyaji, E N</creatorcontrib><creatorcontrib>Wang, D</creatorcontrib><creatorcontrib>Wright, A D</creatorcontrib><creatorcontrib>Collins, A M</creatorcontrib><creatorcontrib>Gordon, S B</creatorcontrib><creatorcontrib>Ferreira, D M</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Mucosal immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Glennie, S</au><au>Gritzfeld, J F</au><au>Pennington, S H</au><au>Garner-Jones, M</au><au>Coombes, N</au><au>Hopkins, M J</au><au>Vadesilho, C F</au><au>Miyaji, E N</au><au>Wang, D</au><au>Wright, A D</au><au>Collins, A M</au><au>Gordon, S B</au><au>Ferreira, D M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage</atitle><jtitle>Mucosal immunology</jtitle><stitle>Mucosal Immunol</stitle><addtitle>Mucosal Immunol</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>9</volume><issue>1</issue><spage>56</spage><epage>67</epage><pages>56-67</pages><issn>1933-0219</issn><eissn>1935-3456</eissn><abstract>Increased nasopharyngeal colonization density has been associated with pneumonia. We used experimental human pneumococcal carriage to investigate whether upper respiratory tract viral infection predisposes individuals to carriage. A total of 101 healthy subjects were screened for respiratory virus before pneumococcal intranasal challenge. Virus was associated with increased odds of colonization (75% virus positive became colonized vs. 46% virus-negative subjects; P =0.02). Nasal Factor H (FH) levels were increased in virus-positive subjects and were associated with increased colonization density. Using an in vitro epithelial model we explored the impact of increased mucosal FH in the context of coinfection. Epithelial inflammation and FH binding resulted in increased pneumococcal adherence to the epithelium. Binding was partially blocked by antibodies targeting the FH-binding protein Pneumococcal surface protein C (PspC). PspC epitope mapping revealed individuals lacked antibodies against the FH binding region. We propose that FH binding to PspC in vivo masks this binding site, enabling FH to facilitate pneumococcal/epithelial attachment during viral infection despite the presence of anti-PspC antibodies. We propose that a PspC-based vaccine lacking binding to FH could reduce pneumococcal colonization, and may have enhanced protection in those with underlying viral infection.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>25921341</pmid><doi>10.1038/mi.2015.35</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1933-0219
ispartof Mucosal immunology, 2016-01, Vol.9 (1), p.56-67
issn 1933-0219
1935-3456
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4703943
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects 631/250/255/1318
631/250/255/2514
631/250/347
631/250/590/2294
Adolescent
Adult
Allergology
Amino Acid Sequence
Antibodies
Antibodies, Bacterial - biosynthesis
Bacterial Adhesion
Bacterial Proteins - chemistry
Bacterial Proteins - genetics
Bacterial Proteins - immunology
Binding Sites
Biomedical and Life Sciences
Biomedicine
Coinfection
Complement Factor H - chemistry
Complement Factor H - genetics
Complement Factor H - immunology
Epitope Mapping
Female
Gastroenterology
Gene Expression Regulation
Humans
Immunity, Innate
Immunity, Mucosal
Immunology
Male
Middle Aged
Molecular Sequence Data
Nasopharynx - immunology
Nasopharynx - microbiology
Nasopharynx - virology
Pneumococcal Infections - immunology
Pneumococcal Infections - microbiology
Pneumococcal Infections - pathology
Pneumococcal Infections - virology
Protein Binding
Respiratory Mucosa - immunology
Respiratory Mucosa - microbiology
Respiratory Mucosa - virology
Respiratory Tract Infections - immunology
Respiratory Tract Infections - microbiology
Respiratory Tract Infections - pathology
Respiratory Tract Infections - virology
Streptococcus pneumoniae - immunology
Streptococcus pneumoniae - pathogenicity
Virus Diseases - immunology
Virus Diseases - pathology
Virus Diseases - virology
title Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T21%3A15%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modulation%20of%20nasopharyngeal%20innate%20defenses%20by%20viral%20coinfection%20predisposes%20individuals%20to%20experimental%20pneumococcal%20carriage&rft.jtitle=Mucosal%20immunology&rft.au=Glennie,%20S&rft.date=2016-01-01&rft.volume=9&rft.issue=1&rft.spage=56&rft.epage=67&rft.pages=56-67&rft.issn=1933-0219&rft.eissn=1935-3456&rft_id=info:doi/10.1038/mi.2015.35&rft_dat=%3Cproquest_pubme%3E4020564281%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1780628171&rft_id=info:pmid/25921341&rfr_iscdi=true